Ibogaine and 5-MeO-DMT Linked to Adverse Health Risks
New data shows these substances carry higher risks of heart issues and suicidal thoughts than other common hallucinogens.
Updated on Oct. 1, 2026 in Substance Abuse
Live Poll
Should the government implement stricter public health surveillance of recreational substance use?
A cross-sectional study of 1,964 adults has identified higher rates of adverse health effects, including cardiac symptoms and suicidal thoughts, among users of ibogaine and 5-MeO-DMT. These findings suggest significant health risks for individuals currently using these substances.
Why it matters
These results provide critical insight into the physical and mental health consequences of using lesser-studied hallucinogenic substances compared to more common options like psilocybin or LSD. Identifying these patterns is an important step in understanding the safety profile of these drugs.
This cross-sectional study of 1,964 adults analyzed self-reported health changes and healthcare use over one year. Findings show significantly higher rates of cardiac symptoms and suicidal thoughts among ibogaine and 5-MeO-DMT users compared to those using psilocybin, LSD, or MDMA.
The players
JAMA Network Open
A peer-reviewed medical journal that publishes original research on clinical care and public health.
The details
Researchers utilized data from the 2025 National Survey Investigating Hallucinogenic Trends to track user-reported outcomes. Participants described health changes attributed to their substance use in the past year, revealing that 74.2% of ibogaine users sought healthcare services. The data highlights a pronounced frequency of heart palpitations, chest pain, and thoughts of death linked to these specific hallucinogens.
Timeline
2025: The National Survey Investigating Hallucinogenic Trends conducted its data collection.
September 29, 2026: The study results were published in JAMA Network Open.
Health Landscape
This research leverages data from the 2025 National Survey Investigating Hallucinogenic Trends to establish a comparative safety profile for emerging substance use. It sits as a critical check against the broader trend of increasing interest in alternative hallucinogenic therapies.
Anyone experiencing physical symptoms like heart palpitations or persistent suicidal thoughts following the use of any substance should seek immediate medical evaluation. These findings emphasize the importance of discussing all substance use honestly with your primary care physician.
The takeaway
These findings indicate that ibogaine and 5-MeO-DMT are associated with substantial risks that differ from other commonly studied hallucinogens. Always consult with a qualified healthcare professional if you or someone you know is struggling with health changes linked to substance use.
Further reading
For broader context on current patterns in substance use and safety data, see Substance Abuse.
Source note: This article includes information reported by Medscape.
Live Poll
Should the government implement stricter public health surveillance of recreational substance use?
